iA Global Asset Management’s Legend Biotech LEGN Stock Holding History

iA Global Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.1M	Sell	211,135 -19,452	-8%	-$525K	0.07%	185
2026 Q1	$4.17M	Buy	230,587 +77,345	+50%	+$1.47M	0.06%	207
2025 Q4	$3.33M	Sell	153,242 -530	-0.3%	-$15.2K	0.04%	229
2025 Q3	$5.01M	Buy	153,772 +13,354	+10%	+$493K	0.07%	181
2025 Q2	$4.98M	Sell	140,418 -28,143	-17%	-$912K	0.08%	170
2025 Q1	$5.72M	Buy	168,561 +92,181	+121%	+$3.31M	0.1%	151
2024 Q4	$2.48M	Buy	+76,380	New	+$3.16M	0.04%	216
2024 Q1	–	Sell	-1,519	Closed	-$91K	–	493
2023 Q4	$91K	Buy	+1,519	New	+$96.3K	﹤0.01%	456

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

iA Global Asset Management's LEGN Position: Q2 2026 in Review

iA Global Asset Management reduced its Legend Biotech (LEGN) stake by 8.4% in Q2 2026, selling an estimated $525K and leaving 211,135 shares worth $6.1M. The position accounts for 0.07% of the portfolio, ranked #185.

iA Global Asset Management first reported a position in LEGN in Q4 2023 and has held it in 8 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

iA Global Asset Management held 211,135 shares of Legend Biotech worth $6.1M as of Q2 2026.
iA Global Asset Management sold 19,452 Legend Biotech shares in Q2 2026, an estimated $525K.
Legend Biotech made up 0.07% of iA Global Asset Management's portfolio in Q2 2026, its #185 holding.
iA Global Asset Management first reported a position in Legend Biotech in Q4 2023 and has held it in 8 quarters since.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.